Evaluating your Block Schedule: Dive Right In


Managing, let alone changing, your organization’s block schedule might feel as intimidating as the thought of diving with sharks. But don’t let it scare you; the benefits far exceed the risks. It’s time to dive in!


The Power of an Enterprise-wide, Data-driven Strategy


Health systems and providers continue to face ongoing challenges associated with delivering high-quality, cost-effective care while balancing decreasing reimbursements and new value-based payment models. COVID-19 has heightened the need for organizations to be adaptable, flexible and reliable. Learn why a comprehensive enterprise-wide data-driven strategy is essential to adapting and thriving in this new environment.  


Health Care Pricing, Doorbells and Peanut Shells


The difference in charges for identical services depending on the source of payment is difficult for patients to understand, and even more difficult for providers to explain. With more intense scrutiny on private sector prices arising from higher insurance deductibles and enthusiasm by policymakers over transparency, it is hard to ignore.


Lessons from the Pandemic: Five Value-based Care Strategies to Consider for 2021


As COVID-19 unfolded across the nation, the risk for health systems with an entirely fee-for-service reimbursement system was exposed. Now nine months into the pandemic, it is increasingly clear that COVID-19 may just be the disruptive force that causes those health systems to move decisively toward a reimbursement structure more aligned with value. Here are five value-based care strategies that should be top of mind going into 2021.



As Administration Releases a Wave of Regulations, are Storms Ahead?


A wave of recent press releases and Federal Register notices finalized several outstanding policy goals for President Trump and HHS. Given the late hour, one might ask: will these regulations stand, or will they change once the administration changes in January?


Bickering in the Back Seat: The Case for All Payer Pricing


In his latest essay entitled “Bickering in the Back Seat: The Case for All Payer Pricing”, Vizient Research Institute executive director Tom Robertson reminisces about a common childhood memory while contemplating the future direction of health care finance. 


What to Consider When Purchasing Mammography Equipment for Your Facility


When digital breast tomosynthesis was approved for mammography by the Food and Drug Administration in 2011, the 3-dimensional technology brought increased insight into women’s health care, but it did not replace 2D imaging. Instead the two systems complemented each other. Today, however, new technology is poised to change that.


A Tale of Two Pandemics


The COVID-19 pandemic, rampant since March, has interrupted life in ways not seen in our country in over a century. With vaccines in development, we just may have a light at the end of the tunnel. The spread of misinformation, the other pandemic, has serious implications for healthcare and no cure in sight. 


It’s Time to Re-evaluate Insurance Coverage for Events With a Deadly Weapon


In settings where employees are entirely focused on providing care, ensuring that patients, visitors and employees alike are safe is of paramount importance. Unfortunately, incidents of violence can occur, and health care providers need to consider how to mitigate and manage these risks.


Health Care Disruption and the Dog that Didn’t Bark


In the year before the global pandemic, Vizient research was calling attention to the vulnerability of the traditional health system business model, highly dependent on enormous profitability on a very small subset of patients to offset unfavorable economics on the bulk of provider volume.